Evidence map›Paper›PMID 29695568›Full record

SynthesisIn vivo (Athens, Greece)

Meta-analysis of Robot-assisted

Hiroshi Ohtani, Kiyoshi Maeda, Shinya Nomura, Osamu Shinto, Yoko Mizuyama, Hiroji Nakagawa, Hisashi Nagahara, Masatsune Shibutani, Tatsunari Fukuoka, Ryosuke Amano and 2 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Robotic surgery for colorectal cancer.Annals of gastroenterological surgery · 2020
    Review
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hiroshi OhtaniDepartment of Surgery, Ohno Memorial Hospital, Osaka, Japan m5051923@msic.med.osaka-cu.ac.jp.
Kiyoshi MaedaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Shinya NomuraDepartment of Surgery, Ohno Memorial Hospital, Osaka, Japan.
Osamu ShintoDepartment of Surgery, Ohno Memorial Hospital, Osaka, Japan.
Yoko MizuyamaDepartment of Surgery, Ohno Memorial Hospital, Osaka, Japan.
Hiroji NakagawaDepartment of Surgery, Ohno Memorial Hospital, Osaka, Japan.
Hisashi NagaharaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Masatsune ShibutaniDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tatsunari FukuokaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Ryosuke AmanoDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kosei HirakawaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Masaichi OhiraDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimA meta-analysis was conducted to evaluate and compare the short- and long-term outcomes of robot-assisted (RAS) and conventional laparoscopic surgery (LAS) for rectal cancer. MATERIALS AND

methodsWe searched MEDLINE for relevant papers published between 2010 and December 2017 by using specific search terms. We analyzed outcomes over short- and long-term periods.

resultsWe identified 23 papers reporting results that compared RAS for rectal cancer with LAS. Our meta-analysis included 4,348 patients with rectal cancer; 2,068 had undergone RAS, and 2,280 had undergone LAS. In the short- and long-term period, 27 and 7 outcome variables were examined, respectively. RAS for rectal cancer was significantly associated with a greater operative time and a lower conversion rate to open surgery in the short-term, and results in almost similar outcomes in the long-term, compared to LAS.

conclusionRAS may be an acceptable surgical treatment option compared to LAS for rectal cancer.

Indexed as

LaparoscopyRobotic Surgical ProceduresBlood Loss, SurgicalChemoradiotherapyClinical Trials as TopicHumansNeoadjuvant TherapyOperative TimePostoperative ComplicationsRectal NeoplasmsTreatment Outcomelaparoscopic surgerymeta-analysisRectal cancerrobot-assisted surgery

Identifiers

PMID29695568
PMCPMC6000779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.